Imetelstat Pregnancy and Breastfeeding Warnings

Brand names: Rytelo

Medically reviewed by Drugs.com. Last updated on Jul 25, 2024.

Imetelstat Pregnancy Warnings

Safety has not been established during pregnancy.

US FDA pregnancy category: Not assigned

Risk summary: Based on findings from animal studies, this drug may cause fetal harm when administered to a pregnant woman. No data available on use of this drug in pregnant women to inform a drug-associated risk.

Comments:
-Verify the pregnancy status of females of reproductive potential prior to initiating treatment.
-Counsel females of childbearing potential to use effective contraception during treatment and for 1 week after the last dose.
-Advise pregnant women of the potential risk to a fetus if this drug is used during pregnancy.
-This drug may (reversibly) impair female fertility.

See references

Imetelstat Breastfeeding Warnings

Breastfeeding is not recommended during use of this drug and for 1 week after the last dose.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-There are no data on the presence of this drug in human milk or the effects of this drug on milk production.
-The effects in the nursing infant are unknown; there is a potential for serious adverse reactions.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer